Delhi-based Dr. Dang's lab partners with Bharat Biotech for human clinical trials of Covaxin | Headlines

www.devdiscourse.com
3 min read
difficult
Delhi-based Dr. Dangs Lab has been selected to partner with Hyderabad-based Bharat Biotech for the human clinical trials of Covaxin, Indias indigenous COVID-19 vaccine. Bharat Biotech is a leading biotechnology company that creates effective vaccines and bio-therapeutics for patients around the world.
Delhi-based Dr. Dangs Lab has been selected to partner with Hyderabad-based Bharat Biotech for the human clinical trials of Covaxin, India's indigenous COVID-19 vaccine. Bharat Biotech is a leading biotechnology company that creates effective vaccines and bio-therapeutics for patients around the world.

"We are extremely privileged to announce that Dr. Dangs Lab, New Delhi has been provided the opportunity to serve the nation by being selected as the central lab for the Human Clinical trials of Covaxin. This is a randomised, double blind, placebo controlled multi centric clinical trial in India," Dr. Dangs Lab said in a statement to ANI. The lab is currently processing all samples for screening and safety for the various phases of this clinical trial, whereas all the efficacy studies will be performed in NIV (Pune).

The lab said it has already started receiving samples from 50 to 100 subjects per day from various trial sites for safety testing and will be increasing operations as per assigned timelines to cover 12 sites across the length and breadth of the country over this month. "Stringent quality norms driven by GCLP guidelines are being followed as mandated by regulatory authorities. The lab has renowned experts in each field who are working tirelessly and collectively to provide quality and timely results to fulfill the imminent need of an effective and safe COVID19…
ANI
Read full article